TXG Stock: 10x Genomics, Inc. Stock Price, Analysis & Insights
Get live txg stock price $16.03, comprehensive 10x Genomics, Inc. stock analysis, charts, news, and expert forecast. Real-time txg stock data and investment insights.
Loading chart...
Company Overview
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Company Information
- CEO
- Serge Saxonov
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 1306
Contact Information
- Website
- https://www.10xgenomics.com
- Address
- 6230 Stoneridge Mall Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.15)
Business Model & Strategy
10x Genomics, Inc. operates in the Medical - Healthcare Information Services industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Serge Saxonov, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Healthcare Information Services model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
10x Genomics, Inc. competes in the Medical - Healthcare Information Services within the broader Healthcare. With 2.0 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, 10x Genomics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating 10x Genomics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for 10x Genomics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for 10x Genomics, Inc.
- ⚠Investors should consider how 10x Genomics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.98B
P/E Ratio
-25.44
Beta
2.15
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.98B market capitalization
- Trading Volume: 459.89K shares traded today
- Price Range: 52-week range of $6.78 - $20.34
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for 10x Genomics, Inc.
10x Genomics, Inc. (TXG) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. With a current market capitalization of 1.98B, the company represents a significant player in its market. The stock is currently trading at $16.03 with a positivedaily change of 2.04%.
The company's 1306 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -25.44, beta of 2.15, and 52-week price range from $6.78 to $20.34when evaluating investment opportunities.
Why Invest in 10x Genomics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Serge Saxonov
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.